C

Codexis
D

CDXS

4.60500
USD
0.27
(6.23%)
مغلق
حجم التداول
13,775
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
374,745,022
أصول ذات صلة
    CI
    CI
    -2.54
    (-0.78%)
    321.53 USD
    D
    DRI
    -1.800
    (-1.07%)
    166.890 USD
    ECL
    ECL
    -2.380
    (-0.96%)
    245.230 USD
    FDX
    FDX
    2.21
    (0.76%)
    294.44 USD
    KR
    KR
    -1.050
    (-1.78%)
    58.040 USD
    LEN
    LEN
    -0.890
    (-0.52%)
    168.900 USD
    MCD
    MCD
    -6.07
    (-2.03%)
    290.22 USD
    ORCL
    ORCL
    -3.380
    (-1.81%)
    192.27 USD
    TJX
    TJX
    0.050
    (0.04%)
    121.46 USD
    TRV
    TRV
    4.27
    (1.66%)
    260.75 USD
    المزيد
الأخبار

العنوان: Codexis

القطاع: Healthcare
الصناعة: Biotechnology
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.